Quantcast

Drug Recall for Two Weight Loss Supplements with Undeclared Pharmaceuticals

Two Weight Loss Supplements Under Drug Recall Due to Undeclared Pharmaceuticals Supplement manufacturer Bethel Nutritional Consulting has issued a voluntary drug recall for two weight loss pharmaceuticals after the FDA informed the company about undeclared pharmaceuticals. The first drug recall involves SLIM-K capsules, which the FDA found contained undeclared Sibutramine, desmethylsibutramine, and Phenolphthalein. Sibutramine was withdrawn from the US market in 2010 because the weight loss drug can increase the risk of heart attacks, … [Read more...]

Drug Recall for Red Yeast Rice Supplement for Undeclared Drugs

Undeclared High Cholesterol Drug Leads to Drug Recall for Red Yeast Rice Dietary Supplement Supplement manufacturer Doctor’s Best has issued a voluntary drug recall for their Red Yeast Rice Dietary supplement due to undeclared cholesterol medication. The dietary supplement was found to have undeclared lovastatin, a generic drug used to treat high cholesterol, but which can have serious side effects with long-term use. In rare cases of long-term or high dose use, lovastatin can cause serious muscle injury. The risk of muscle injury is … [Read more...]

Supplement Under Drug Recall Due to Ingredients

Manufacturer Issues Voluntary Drug Recall Due Undeclared Ingredients in Weight Loss Supplement Supplement distributor Bacai has issued a voluntary drug recall for its weight loss supplement, LiteFit, due to undeclared drugs. The FDA stated that tests on LiteFit showed a substance that the administration banned in 2010 because it poses a serious health threat. Sibutramine was used as a weight loss drug until the FDA banned it because the substance increased blood pressure and/or pulse rate, which can cause serious side effects for people … [Read more...]